- Home
- MRBK vs FBIOP Comparison
MRBK vs FBIOP Comparison
Compare MRBK & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- FBIOP
- Stock Information
- Founded
- MRBK 2004
- FBIOP N/A
- Country
- MRBK United States
- FBIOP United States
- Employees
- MRBK N/A
- FBIOP 101
- Industry
- MRBK Major Banks
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- MRBK Finance
- FBIOP Health Care
- Exchange
- MRBK Nasdaq
- FBIOP Nasdaq
- Market Cap
- MRBK N/A
- FBIOP N/A
- IPO Year
- MRBK 2017
- FBIOP N/A
- Fundamental
- Price
- MRBK $13.95
- FBIOP $6.70
- Analyst Decision
- MRBK Buy
- FBIOP
- Analyst Count
- MRBK 2
- FBIOP 0
- Target Price
- MRBK $16.00
- FBIOP N/A
- AVG Volume (30 Days)
- MRBK 56.3K
- FBIOP N/A
- Earning Date
- MRBK 05-06-2025
- FBIOP N/A
- Dividend Yield
- MRBK 3.59%
- FBIOP N/A
- EPS Growth
- MRBK 25.00
- FBIOP N/A
- EPS
- MRBK 1.45
- FBIOP N/A
- Revenue
- MRBK $100,935,000.00
- FBIOP N/A
- Revenue This Year
- MRBK $22.20
- FBIOP N/A
- Revenue Next Year
- MRBK $9.93
- FBIOP N/A
- P/E Ratio
- MRBK $9.61
- FBIOP N/A
- Revenue Growth
- MRBK 7.27
- FBIOP N/A
- 52 Week Low
- MRBK $8.69
- FBIOP N/A
- 52 Week High
- MRBK $17.33
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- MRBK 52.73
- FBIOP 66.72
- Support Level
- MRBK $13.07
- FBIOP $6.00
- Resistance Level
- MRBK $14.13
- FBIOP $6.80
- Average True Range (ATR)
- MRBK 0.79
- FBIOP 0.41
- MACD
- MRBK 0.16
- FBIOP 0.18
- Stochastic Oscillator
- MRBK 75.28
- FBIOP 90.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.